Product Images Metoprolol Succinate

This is a description of Metoprolol Succinate Extended-Release Tablets. Each tablet contains 47.5mg metoprol succinate which is equivalent to 50mg metoprol tartrate, USP. There are 30 tablets in a container and it is only available with a prescription. Recommended storage temperature is between 15°C-30°C (56°-86°F), stored in the original container, and protected from moisture. It must be kept out of the reach of children. The LCN number is 00 and it was repackaged by Northwind Pharmaceuticals in Indianapolis, IN. The NDC number is 51655-597-52 and the GTIN number is 0351655597521. Lot number and expiry date are not available.*

This is a description of Metoprolol Succinate ER, a prescription drug indicated for the treatment of hypertension (high blood pressure) and angina (chest pain). It is available in a bottle of 30 tablets, each containing 100 mg of metoprolol succinate, an extended-release formulation. The drug should be stored at a temperature between 15°C to 30°C (58°F to 86°F) protected from moisture and out of children's reach. The medication should be taken as per the package insert. The drug is repackaged by Northwind Pharmaceuticals. The NDC code is 51655-615-52, and the GTIN is 0351655615522. It was originally packaged by Twi Pharmaceuticals USA, Inc. The Lot number is 0000000000, and the Expiration date is 00/00/0000.*

This text provides data on the results of a study called MERIT-HF, which evaluated the effects of Wetoprolol Succinate Extended-Release tablets on total mortality or hospitalization for heart failure in different subgroups of patients. The subgroups were categorized based on various factors such as age, sex, race, history of heart disease, diabetes, and hypertension, among others. The study reports that Wetoprolol Succinate Extended-Release tablets were associated with a lower risk of total mortality or hospitalization for heart failure in some subgroups compared to placebo. The study was conducted in the US and non-US, and the patients' status was categorized according to NYHA classes I, II, and IV. The text also includes information about the mean ejection fraction, heart rate, and ischemic or non-ischemic etiology of heart disease in the subgroups.*